Back to Blog
Peptide Science••10 min read
TB-500 and Cardiac Recovery: What the 2026 Human Trial Data Shows
TB-500 has moved from rodent models to human cardiac recovery trials. The 2026 data is early, but the mechanism and results are worth understanding — especially if you're using TB-500 for recovery.
PeptIQ Research Team
Editorial
#TB-500#human trials#Thymosin Beta-4#cardiac recovery#cardiovascular#clinical data#recovery
Track Your Peptide Protocols
Use PeptIQ to log injections, calculate doses, access our peptide library, and optimize your protocols.
Download PeptIQ
